Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

April 2, 2026

Pinterest said he violated laid-off colleagues’ privacy. Now he’s going public

April 2, 2026

Pick Your Perfect Cultural Escape During MOSAIC

April 2, 2026

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

April 2, 2026

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

April 2, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » USE.com Announces It Has Already Raised Over $1.5 Million as Phase 3 Presale Is Now Live
Press Release

USE.com Announces It Has Already Raised Over $1.5 Million as Phase 3 Presale Is Now Live

By News RoomJanuary 2, 20263 Mins Read
USE.com Announces It Has Already Raised Over .5 Million as Phase 3 Presale Is Now Live
Share
Facebook Twitter LinkedIn Pinterest Email

DUBAI, United Arab Emirates, Jan. 02, 2026 (GLOBE NEWSWIRE) — USE.com, a next-generation centralized cryptocurrency exchange currently in development, today announced that it has already raised more than $1.5 million through its ongoing token presale, as Phase 3 officially goes live. USE tokens are now available at $0.20, with a scheduled price increase to $0.25 in the next phase. The milestone highlights growing early interest as investors increasingly prioritize infrastructure-driven platforms over short-term speculative launches.

The USE.com presale has shown steady participation, with more than 10.75 million USE tokens sold to date. Out of the 70 million tokens allocated for the presale, a significant portion has already been acquired, reflecting consistent demand rather than a single surge of speculative activity. Market observers often interpret this pattern as a sign of sustained confidence during early-stage fundraising.

USE.com has committed to a fixed total supply of 200 million USE tokens, with no plans for future dilution. According to analysts, supply certainty remains a key consideration for long-term participants, particularly as the market matures and token economics face increased scrutiny.

Designed as a professional-grade centralized exchange, USE.com is being built to support spot trading, margin trading, perpetual contracts, copy trading, and advanced APIs, alongside smart order routing intended to reduce slippage. The platform’s development strategy emphasizes scalability, liquidity depth, and performance for both retail and professional traders.

Security is positioned as a core component of the platform’s architecture. Planned features include on-chain Proof-of-Reserves, segregated user custody, and a $25 million insurance fund aimed at protecting user assets. These measures reflect broader industry efforts to rebuild trust and transparency following recent market disruptions.

In addition to token ownership, presale participants are eligible for platform-based benefits, including lifetime trading fee rebates of up to 30%, priority access to the USE Launchpad, preferred staking yields, and VIP trading tiers for higher-balance holders. Analysts note that incentives tied directly to platform usage may help support long-term engagement rather than short-term speculation.

According to the project roadmap, USE.com plans to launch a public beta and spot trading in Q2 2026, followed by margin trading, perpetuals, and institutional-grade features later in the year. The team has stated a long-term objective of reaching 100 million verified users by Q2 2027.

While market outcomes remain uncertain, analysts cite USE.com’s early fundraising traction, fixed supply model, and product-first development approach as reasons the Phase 3 presale is attracting increasing attention.

About USE.com

USE.com is a centralized cryptocurrency exchange currently in development, focused on building a scalable, secure, and performance-driven trading platform for global users. The exchange aims to combine institutional-grade infrastructure with user-centric incentives designed for long-term participation.

For more information, please visit:
Website: https://use.com/
Whitepaper: https://docs.use.com/whitepaper/whitepaper
X (Twitter): https://x.com/useexchange
Telegram: https://t.me/useglobal


            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

Pick Your Perfect Cultural Escape During MOSAIC

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

Real Music. Real Artists. Mini Size

Global Interventional Oncology Industry Set to Grow by $1.18 Billion During 2026-2030 – AI-Assisted Imaging and Minimally Invasive Procedures Drive Interventional Oncology Expansion

ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

Dr. Kofi Sarfo Scholarship for Future Doctors Launches 2026 Application Cycle to Support the Next Generation of Physicians

Sizeprop Partners with Pudgy Penguins to Launch Open Prop Trading Competition

Editors Picks

Pinterest said he violated laid-off colleagues’ privacy. Now he’s going public

April 2, 2026

Pick Your Perfect Cultural Escape During MOSAIC

April 2, 2026

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

April 2, 2026

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

April 2, 2026

Latest News

Real Music. Real Artists. Mini Size

April 2, 2026

Global Interventional Oncology Industry Set to Grow by $1.18 Billion During 2026-2030 – AI-Assisted Imaging and Minimally Invasive Procedures Drive Interventional Oncology Expansion

April 2, 2026

ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

April 2, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version